FI895555A0 - Förfarande för framställning av ett läkemedelsavgivande system - Google Patents

Förfarande för framställning av ett läkemedelsavgivande system

Info

Publication number
FI895555A0
FI895555A0 FI895555A FI895555A FI895555A0 FI 895555 A0 FI895555 A0 FI 895555A0 FI 895555 A FI895555 A FI 895555A FI 895555 A FI895555 A FI 895555A FI 895555 A0 FI895555 A0 FI 895555A0
Authority
FI
Finland
Prior art keywords
preparation
delivery system
drug delivery
drug
delivery
Prior art date
Application number
FI895555A
Other languages
English (en)
Finnish (fi)
Other versions
FI97444B (sv
FI97444C (sv
Inventor
Lisbeth Illum
Original Assignee
Danbiosyst Uk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst Uk filed Critical Danbiosyst Uk
Publication of FI895555A0 publication Critical patent/FI895555A0/sv
Publication of FI97444B publication Critical patent/FI97444B/sv
Application granted granted Critical
Publication of FI97444C publication Critical patent/FI97444C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FI895555A 1987-05-22 1989-11-21 Förfarande för framställning av ett läkemedelsavgivande system FI97444C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878712176A GB8712176D0 (en) 1987-05-22 1987-05-22 Drug delivery system
GB8712176 1987-05-22
PCT/GB1988/000396 WO1988009163A1 (en) 1987-05-22 1988-05-20 Enhanced uptake drug delivery system
GB8800396 1988-05-20

Publications (3)

Publication Number Publication Date
FI895555A0 true FI895555A0 (sv) 1989-11-21
FI97444B FI97444B (sv) 1996-09-13
FI97444C FI97444C (sv) 1996-12-27

Family

ID=10617794

Family Applications (1)

Application Number Title Priority Date Filing Date
FI895555A FI97444C (sv) 1987-05-22 1989-11-21 Förfarande för framställning av ett läkemedelsavgivande system

Country Status (10)

Country Link
EP (1) EP0391896B1 (sv)
JP (1) JP2914670B2 (sv)
AU (1) AU614290B2 (sv)
CA (1) CA1324079C (sv)
DE (1) DE3888201T2 (sv)
DK (1) DK175316B1 (sv)
FI (1) FI97444C (sv)
GB (2) GB8712176D0 (sv)
NO (1) NO178564C (sv)
WO (1) WO1988009163A1 (sv)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8720442A (nl) * 1986-08-18 1989-04-03 Clinical Technologies Ass Afgeefsystemen voor farmacologische agentia.
US4865850A (en) * 1986-09-08 1989-09-12 See/Shell Biotechnology, Inc. Dietary fat reduction
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5811128A (en) * 1986-10-24 1998-09-22 Southern Research Institute Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
US5298243A (en) * 1988-10-20 1994-03-29 Denki Kagaku Kogyo Kabushiki Kaisha Colony stimulating factor-gelatin conjugate
ES2089011T3 (es) * 1989-02-17 1996-10-01 Liposome Co Inc Excipiente lipidico de administracion nasal y aplicacion topica.
US5554388A (en) * 1989-02-25 1996-09-10 Danbiosyst Uk Limited Systemic drug delivery compositions comprising a polycationi substance
EP0465580A4 (en) * 1989-03-29 1992-03-18 Alcon Laboratories Inc Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs
GB8918879D0 (en) * 1989-08-18 1989-09-27 Danbiosyst Uk Pharmaceutical compositions
US5725871A (en) * 1989-08-18 1998-03-10 Danbiosyst Uk Limited Drug delivery compositions comprising lysophosphoglycerolipid
US5707644A (en) * 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
GB9012663D0 (en) * 1990-06-07 1990-08-01 Erba Carlo Spa Galenic formulations containing cyclodextrins
DK49791D0 (da) * 1991-03-20 1991-03-20 Novo Nordisk As Nasalt pulverpraeparat
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
US5482706A (en) * 1992-04-17 1996-01-09 Takeda Chemical Industries, Ltd. Transmucosal therapeutic composition
CA2150803C (en) * 1992-12-02 2006-01-31 Henry Auer Controlled release growth hormone containing microspheres
US5549908A (en) * 1993-05-20 1996-08-27 The University Of Akron Hydrolytically labile microspheres of polysaccharide crosslinked with cyanogen halide and their application in wound dressings
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5830853A (en) * 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
US5747445A (en) * 1993-06-24 1998-05-05 Astra Aktiebolag Therapeutic preparation for inhalation
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US6165976A (en) * 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
DK0806945T3 (da) 1994-12-22 2003-08-04 Astrazeneca Ab Terapeutisk præparat til inhalering, indeholdende parathyroideahormon, PTH
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
GB9522351D0 (en) * 1995-11-01 1996-01-03 Medeva Holdings Bv Vaccine compositions
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
GB9700624D0 (en) 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
JP2000290184A (ja) * 1999-04-01 2000-10-17 Kyowa Hakko Kogyo Co Ltd 経鼻投与製剤
US7833549B2 (en) * 2000-01-19 2010-11-16 Mannkind Corporation Dry powder formulations of antihistamine for nasal administration
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
MXPA02001323A (es) 2000-05-10 2004-07-16 Alliance Pharma Microgranulos con base fosfolipida para la liberacion de farmaco.
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
WO2003026699A1 (fr) * 2001-09-26 2003-04-03 Tanabe Seiyaku Co., Ltd. Compositions medicinales favorisant l'absorption de medicaments
ATE508735T1 (de) 2001-12-19 2011-05-15 Novartis Ag Pulmonale verabreichung von aminoglykosiden
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
NL1022442C2 (nl) * 2003-01-20 2004-07-22 Tno Toepassing van lipide ter verbetring van de opname van nutrienten en (farmaceutisch) actieve stoffen.
US7591999B2 (en) * 2003-03-04 2009-09-22 Mitsubishi Tanabe Pharma Corporation Powdery preparation for nasal administration
CA2528465A1 (en) * 2003-06-09 2005-01-20 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of growth hormone
MX350838B (es) 2011-02-11 2017-09-18 Grain Proc Corporation * Composicion de sal.
EP3099293B1 (en) 2014-01-27 2020-11-18 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Nanoencapsulation of hydrophilic active compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681500A (en) * 1969-12-12 1972-08-01 Boehringer Sohn Ingelheim Spray compositions for treatment of obstructive disorders of the respiratory tract and methods therefor
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
EP0257915B1 (en) * 1986-08-11 1993-03-10 Innovata Biomed Limited Pharmaceutical formulations comprising microcapsules

Also Published As

Publication number Publication date
GB8924696D0 (en) 1990-09-05
JPH02503915A (ja) 1990-11-15
EP0391896A1 (en) 1990-10-17
AU614290B2 (en) 1991-08-29
FI97444B (sv) 1996-09-13
GB2231495B (en) 1991-08-28
GB2231495A (en) 1990-11-21
JP2914670B2 (ja) 1999-07-05
NO178564B (no) 1996-01-15
FI97444C (sv) 1996-12-27
CA1324079C (en) 1993-11-09
DK583789A (da) 1990-01-18
NO890283D0 (no) 1989-01-23
DK583789D0 (da) 1989-11-21
DK175316B1 (da) 2004-08-16
WO1988009163A1 (en) 1988-12-01
EP0391896B1 (en) 1994-03-02
NO178564C (no) 1996-04-24
AU1793188A (en) 1988-12-21
GB8712176D0 (en) 1987-06-24
DE3888201D1 (de) 1994-04-07
NO890283L (no) 1989-01-23
DE3888201T2 (de) 1994-07-14

Similar Documents

Publication Publication Date Title
FI895555A0 (sv) Förfarande för framställning av ett läkemedelsavgivande system
FI901787A0 (sv) Förfarande för framställning av en läkemedel avgivande komposition
FI885884A0 (sv) Förfarande för framställning av en långsamt frigörande farmaceutisk komposition
FI98196B (sv) Förfarande för framställning av en farmaceutisk beredning omfattande en mikroemulsion
FI884526A (sv) Förfarande för framställning av en dosform avgivande av isradipin
FI880928A0 (sv) Förfarande för framställning av en farmaceutisk tablett och ett farmaceutiskt granulat
NO175515C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat for perkutan tilförsel
NO177038C (no) Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem
FI894342A0 (sv) Förfarande för framställning av en cyklosporin innehållande farmaceutisk sammansättning
FI893520A0 (sv) Förfarande för framställning av en intravenös farmaceutisk sammansättning
FI900604A0 (sv) Förfarande för framställning av en farmaceutisk sammansättning innehållande cyklosporin
FI880436A0 (sv) Förfarande för behandling av ett fluorescerande ämne
DK528988A (da) Laegemiddelafgivelsessystem
FI860101A0 (sv) Analogiförfarande för framställning av ett nytt läkemedel
FI883261A0 (sv) Förfarande för framställning av en farmaceutisk komposition innefattande en somatostatinanalog
FI892058A0 (sv) Förfarande för framställning av fenol
FI880869A (sv) Förfarande för framställning av terapeutiskt aktiva tetrazolderivat
FI881303A (sv) Förfarande för framställning av ibuprofen
FI875102A0 (sv) Analogiförfarande för framställning av ett såsom läkemedel användbart imidazolderivat
FI104171B1 (sv) Förfarande för framställning av mono-N-alkylerade polyazamakrocykliska föreningar
NO177485C (no) Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat
FI92065C (sv) Förfarande för framställning av farmaceutiska piperidinderivat
NO179396C (no) Fremgangsmåte ved fremstilling av en medikamentell administreringsform for drövtyggere
FI913554A (sv) Förfarande för framställning av en stabiliserad farmaceutisk komposition
FI99080B (sv) Förfarande för framställning av emulsioner för parenteral administrering

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: WEST PHARMACEUTICAL SERVICES DRUG DELIVERY & CLINI

MA Patent expired